Old Web
English
Sign In
Acemap
>
authorDetail
>
Hilma J. van der Horst
Hilma J. van der Horst
VU University Medical Center
Antibody
Medicine
Cancer research
Immunology
Multiple myeloma
4
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant.
2021
Lisa C. Holthof
Arwen Stikvoort
Hilma J. van der Horst
Anne T. Gelderloos
Renée Poels
Fengzhi Li
Richard W.J. Groen
Sonja Zweegman
Niels W.C.J. van de Donk
Michael ODwyer
Tuna Mutis
Show All
Source
Cite
Save
Citations (4)
The Impact and Modulation of Microenvironment-Induced Immune Resistance Against CAR T Cell and Antibody Treatments in Multiple Myeloma
2019
Blood
Lisa C. Holthof
Hilma J. van der Horst
Renée Poels
Jort T. van der Schans
Anne T. Gelderloos
Fengzhi Li
Henk M. Lokhorst
Sonja Zweegman
Maria Themeli
Niels W.C.J. van de Donk
Richard W.J. Groen
Tuna Mutis
Show All
Source
Cite
Save
Citations (6)
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma
2019
Haematologica
Lisa C. Holthof
Hilma J. van der Horst
Susan E. van Hal van Veen
Ruud W.J. Ruiter
Fengzhi Li
Marijke Buijze
Morten Nørgaard Andersen
Huipin Yuan
Joost D. de Bruijn
Niels W.C.J. van de Donk
Henk M. Lokhorst
Sonja Zweegman
Richard W.J. Groen
Tuna Mutis
Show All
Source
Cite
Save
Citations (7)
Potent Ex Vivo Anti-Tumor Activity in Relapsed Refractory Multiple Myeloma Using Novel DR5-Specific Antibodies with Enhanced Capacity to Form Hexamers upon Target Binding
2017
Blood
Hilma J. van der Horst
Marije B. Overdijk
Esther C.W. Breij
Martine E.D. Chamuleau
Henk M. Lokhorst
Tuna Mutis
Show All
Source
Cite
Save
Citations (4)
1